The largest database of trusted experimental protocols

3 protocols using anti acsl4

1

Ferroptosis-Inhibition Compound Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ferrostatin-1 (347174-05-4), liproxstatin-1 (950455-15-9), trolox (53188-07-1), deferoxamine (138-14-7), RSL-3 (1219810-16-8), erastin (571203-78-6), sulfasalazine (599-79-1), atorvastatin (599-79-1), KU60019 (925701-46-8) were purchased from Cayman. The concentration used is shown in Supplementary Table. S1. C11BODIPY (D3861) was purchased from Invitrogen. Mouse recombinant IFNγ (485-MI-100), anti-mouse IFNγ block antibody (MAB485), human recombinant IFNγ (285-IF-100) were purchased from R&D. Anti-mouse IFNGR1 antibody (16-1193-85) was purchased from Thermo Fisher. The following antibody were used for immunoblots: anti-human SLC7A11 antibody (12691), anti-β-actin (12262), anti-GAPDH (2118), anti-STAT1 (9172), anti-phospho-STAT1 (9167), anti-ATM (2873) and anti-ACSL4 (4047) were bought from Cell Signaling Technology. Anti-GPX4 (ab41787) was from Abcam. Additionally, IgG (BE0087, BE0090), anti-mouse CTLA4 (BE0131), anti-mouse PD-L1 (BE0101) and anti-mouse CD8 (BE0117) were purchased from BioXcell. 4-HNE antibody (ab46545) was purchased from Abcam. Cyst(e)inase was generated as previously described (18 (link)).
+ Open protocol
+ Expand
2

Western Blot Analysis of Ferroptosis Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissues and Cells were lysed in the lysis buffer (RIPA, Beyotime, China). The protein concentrations were measured by the BCA assay kit (Beyotime, China). Equal amounts of protein were loaded in 10% sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) and were then transferred from the gel to polyvinylidene fluoride membranes (Millipore, USA). After blocking in a solution of 5% bovine serum albumin (BSA, Solarbio, China) for 1 h, the membranes were washed with TBST and then incubated with primary antibodies overnight at 4 °C. The following antibodies were used: anti-GPX4(1:2000), anti-4 Hydroxynonenal(1:1000, ab46545, Abcam, USA), anti-ACSL4(1:2000), anti-actin(1:2000, 4967, Cell Signaling Technology, USA). After washing, the membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies for 1 h at 37 °C: goat anti-rabbit IgG antibody (1:2000, #7074, Cell Signaling Technology, USA). Bound antibodies were detected using the ECL western blotting detection system (Millipore, USA).
+ Open protocol
+ Expand
3

Molecular Mechanisms of HUVEC Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
After different treatments, the HUVECs were washed twice with cold PBS. Total cellular proteins were extracted using radioimmunoprecipitation assay buffer (RIPA) buffer. Protein concentrations were determined using a bicinchoninic acid protein assay kit (Beyotime Institute of Biotechnology). Equal amounts of proteins were separated using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The separated proteins were transferred onto polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA). Then, the membranes were blocked with 5% skimmed milk in TBST at room temperature for 1 h. The blots were incubated at 4°C overnight with the following primary antibodies from Abcam: anti-GPX4 (1: 5000), anti-SLC7A11 (1: 1000), anti-ACSL4 (1: 10000), anti-HO-1 (1: 2000), anti-KLF4 (1: 1000), and anti-β-actin (1: 1000), and with the following primary antibodies from Cell Signaling Technology: anti-p-AMPK (1: 1000), anti-AMPK (1: 1000), anti-SOD-1(1: 1000), and anti-SOD-2 (1: 1000). Then, the blots were incubated with HRP-conjugated secondary antibodies (1: 5000) for 1 h at room temperature. Subsequently, blots were developed using enhanced chemiluminescence (Model 6600; Tanon, Shanghai, China).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!